AAPS PharmSciTech

, Volume 14, Issue 3, pp 1118–1128 | Cite as

RETRACTED ARTICLE: Meloxicam Taste-Masked Oral Disintegrating Tablet with Dissolution Enhanced by Ion Exchange Resins and Cyclodextrin

  • Wipada Samprasit
  • Prasert Akkaramongkolporn
  • Tanasait Ngawhirunpat
  • Theerasak Rojanarata
  • Praneet Opanasopit
Research Article

Abstract

The purpose of this study was to develop taste-masked oral disintegrating tablets (ODTs) using the combination of ion exchange resin and cyclodextrin, to mask the bitter taste and enhance drug dissolution. Meloxicam (MX) was selected as a model drug with poor water solubility and a bitter taste. Formulations containing various forms of MX (free drug, MX-loaded resin or resinate, complexes of MX and 2-hydroxypropyl-β-cyclodextrin (HPβCD) or MX/HPβCD complexes, and a mixture of resinate and MX/HPβCD complexes) were made and tablets were prepared by direct compression. The ODTs were evaluated for weight variation, thickness, diameter, hardness, friability, disintegration time, wetting time, MX content, MX release, degree of bitter taste, and stability. The results showed that thickness, diameter, weight, and friability did not differ significantly for all of these formulations. The tablet hardness was approximately 3 kg/in.2, and the friability was less than 1%. Tablets formulated with resinate and the mixture of resinate and MX/HPβCD complexes disintegrated rapidly within 60 s, which is the acceptable limit for ODTs. These results corresponded to the in vivo disintegration and wetting times. However, only tablets containing the mixture of resinate and MX/HPβCD complexes provided complete MX dissolution and successfully masked the bitter taste of MX. In addition, this tablet was stable at least 6 months. The results from this study suggest that the appropriate combination of ion exchange resin and cyclodextrin could be used in ODTs to mask the bitter taste of drug and enhance the dissolution of drugs that are weakly soluble in water.

KEY WORDS

cyclodextrin ion exchange resins oral disintegrating tablet taste masking 

REFERENCES

  1. 1.
    Sastry SV, Nyshadham JR, Fıx JA. Recent technological advances in oral drug delivery—a review. Pharm Sci Technol Today. 2000;3(4):138–45.PubMedCrossRefGoogle Scholar
  2. 2.
    Hirani JJ, Rathod DA, Vadalia KR. Orally disintegrating tablets: a review. Trop J Pharm Res. 2009;8:161–72.CrossRefGoogle Scholar
  3. 3.
    Mohapatra A, Parikh RK, Gohel MC. Formulation, development and evaluation of patient friendly dosage forms of metformin, part—I: orally disintegrating tablets. Asian J Pharm. 2008;2:167–71.CrossRefGoogle Scholar
  4. 4.
    Bhise K, Shaikh S, Bora D. Taste Mask, design and evaluation of an oral formulation using ion exchange resin as drug carrier. AAPS PharmSciTech. 2008;9(2):557–62.PubMedCentralPubMedCrossRefGoogle Scholar
  5. 5.
    Anand V, Kandarapu R, Garg S. Ion-exchange resins: carrying drug delivery forward. Drug Discov Today. 2001;6:905–14.PubMedCrossRefGoogle Scholar
  6. 6.
    Burke GM, Mendes RW, Jambhekar SS. Investigation of the application of ion exchange resins as a sustained release drug delivery system for propranolol hydrochloride. Drug Dev Ind Pharm. 1986;12:713–32.CrossRefGoogle Scholar
  7. 7.
    Leea CW, Kima SJ, Youna YS, Widjojokusumoa E, Leea YH, Kimb J, et al. Preparation of bitter taste masked cetirizine dihydrochloride/β-cyclodextrin inclusion complex by supercritical antisolvent (SAS) process. J Supercrit Fluid. 2010;5(1):348–57.CrossRefGoogle Scholar
  8. 8.
    Brewster ME, Loftsson T. Cyclodextrins as pharmaceutical solubilizers. Advanced Drug Delivery Reviews. 2007;59:645–66.PubMedCrossRefGoogle Scholar
  9. 9.
    Loftsson T, Brewster ME. Pharmaceutical applications of cyclodextrins. 1. Drug solubilization and stabilization. J Pharm Sci. 1996;85:1017–25.PubMedCrossRefGoogle Scholar
  10. 10.
    The United State Pharmacopoeia XXXII/National FormulationXXVII. The United States Pharmacopoeial Convention. Rockville, MD; 2009.Google Scholar
  11. 11.
    Kunin R. Ion exchange resins. New York: Wiley; 1963.Google Scholar
  12. 12.
    Sriwongjanya M, Bodmeier R. Entrapment of drug-loaded ion-exchange particles within polymeric microparticles. Int J Pharm. 1997;158:29–38.CrossRefGoogle Scholar
  13. 13.
    Samprasit W, Rojanarata T, Akkaramongkolporn P, Ngawhirunpat T, Sila-On W, Opanasopit P. Improvement of drug loading onto ion exchange resin by cyclodextrin inclusion complex. Drug Dev Ind Pharm. 2013. doi:10.3109/03639045.2012.729593.
  14. 14.
    Job P. Job’s plot analyses for the 2-CG and 3-CG complexes were consistent with 1:1 stoichiometry. Ann Chim. 1928;9:113–34.Google Scholar
  15. 15.
    Guo X, Chang RK, Hussain MA. Ion-exchange resins as drug delivery carriers. J Pharm Sci. 2009;98(11):3886–902.PubMedCrossRefGoogle Scholar
  16. 16.
    Gohel M, Patel M, Amin A, Agrawal R, Dave R, Bariya N. Formulation design and optimization of mouth dissolve tablets of nimesulide using vacuum drying technique. AAPS PharmSciTech. 2004;36:1–6.Google Scholar
  17. 17.
    Bi Y, Sunada H, Yonezawa Y, Danjo K, Otsuka A, Iida K. Preparation and evaluation of a compressed tablet rapidly disintegrating in the oral cavity. Chem Pharm Bull. 1996;44:2121–7.PubMedCrossRefGoogle Scholar
  18. 18.
    Luger P, Daneck K, Trummlitz WEG, Wagner K. Structure and physicochemical properties of meloxicam, a new NSAID. Eur J Pharm Sci. 1996;4:175–87.CrossRefGoogle Scholar
  19. 19.
    Pisal S, Zainnuddin R, Nalawade P, Mahadik K, Kadam S. Molecular properties of ciprofloxacin-Indion 234 complexes. AAPS PharmSciTech. 2004;5(4):1–8.CrossRefGoogle Scholar
  20. 20.
    Sriwongjanya M, Bodmeier R. Entrapment of drug-loaded ion-exchange particles within polymeric microparticles. Int J Pharm. 1997;158:29–38.CrossRefGoogle Scholar
  21. 21.
    Dowex product literature. http://www.dow.com. Accessed 26 Nov 2012.
  22. 22.
    Jeong SH, Park K. Drug loading and release properties of ion-exchange resin complexes as a drug delivery matrix. Int J Pharm. 2008;361:26–32.PubMedCrossRefGoogle Scholar
  23. 23.
    Higuchi T, Kristiansen H. Binding specificities between small organic solutes in aqueous solutions: classification of some solutes onto two groups according to binding tendencies. J Pharm Sci. 1970;59:1601–8.PubMedCrossRefGoogle Scholar
  24. 24.
    Obaidat AA, Khanfar RA, Khawam MN. The effect of β-cyclodextrin on the solubility and dissolution rate of meloxicam and investigation of the driving force for complexation using molecular modeling. J Incl Phenom Macrocycl Chem. 2009;63:273–9.CrossRefGoogle Scholar
  25. 25.
    Sinko PJ. Martin’s physical pharmacy and pharmaceutical sciences. London: Lippincott Williams & Wilkins; 2011. p. 197–222.Google Scholar
  26. 26.
    Jug M, Bećirević-Laćan M. Influence of hydroxypropyl-β-cyclodextrin complexation on piroxicam release from buccoadhesive tablets. Eur J Pharm Sci. 2004;21:251–60.PubMedCrossRefGoogle Scholar
  27. 27.
    Sheshala R, Khan N, Chitneni M, Darwis Y. Formulation and in vivo evaluation of ondansetron orally disintegrating tablets using different superdisintegrants. Arch Pharm Res. 2011;34(11):1945–56.PubMedCrossRefGoogle Scholar
  28. 28.
    Fenyresi E, Shirankura O, Szejtli J, Nagai T. Properties of cyclodextrin polymer as a tableting aid. Chem Pharm Bull. 1984;32:665–9.CrossRefGoogle Scholar
  29. 29.
    Ghorab MM, Abdel-Salam HM, El-Sayad MA, Mekhel MM. Tablet formulation containing meloxicam and β-cyclodextrin: mechanical characterization and bioavailability evaluation. AAPS PharmSciTech. 2004;5(4):1–6.CrossRefGoogle Scholar
  30. 30.
    Rudnic EM, Rhodes CT, Welsh S, Bernardo P. Evaluation of the mechanism of disintegrant action. Drug Dev Ind Pharm. 1982;8:87–109.CrossRefGoogle Scholar
  31. 31.
    Amberlite product literature. http://www.rohmhaas.com. Accessed 26 Nov 2012.
  32. 32.
    Akkaramongkolporn P, Ngawhirunpat T, Nunthanid J, Opanasopit P. Effect of a pharmaceutical cationic exchange resin on the properties of controlled release diphenhydramine hydrochloride matrices using Methocel K4M or Ethocel 7cP as matrix formers. AAPS PharmSciTech. 2008;9(3):899–908.PubMedCentralPubMedCrossRefGoogle Scholar
  33. 33.
    Sriwongjanya M, Bodmeier R. Effect of ion exchange resins on the drug release from matrix tablets. Eur J Pharm Biopharm. 1998;46:321–7.PubMedCrossRefGoogle Scholar
  34. 34.
    Pattarakan N, Opanasopit P, Ngawhirunpat T, Akkaramongkolporn P. Application of ion exchange resins as tablet disintegrants. The 26th Annual Research Conference in Pharmaceutical Science. 04 December 2009. Bangkok, Thailand.Google Scholar
  35. 35.
    Kornblum SS, Stoopak SB. A new tablet disintegrating agent: cross-linked polyvinylpyrrolidone. J Pharm Sci. 1973;62(1):43–9.PubMedCrossRefGoogle Scholar
  36. 36.
    Jivraj M, Martini LG, Thomson CM. An overview of the different excipients useful for the direct compression of tablets. Pharm Sci Tech Today. 2000;3:58–62.CrossRefGoogle Scholar
  37. 37.
    Narazaki R, Harada T, Takami N, Kato Y, Ohwaki T. A new method for disintegration studies of rapid disintegrating tablet. Chem Pharm Bull. 2004;52(6):704–7.PubMedCrossRefGoogle Scholar
  38. 38.
    Bi Y, Hisakadzu S. Preparation and evaluation of a compressed tablet rapidly disintegrating in the oral cavity. Chem Pharm Bull. 1996;44:2121–7.PubMedCrossRefGoogle Scholar
  39. 39.
    Fenyresi E, Shirankura O, Szejtli J, Nagai T. Properties of cyclodextrin polymer as a tableting aid. Chem Pharm Bull. 1984;32:665–9.CrossRefGoogle Scholar
  40. 40.
    Jinichi F, Etsuo Y, Yasuo Y, Terada K. Evaluation of rapidly disintegrating tablets containing glycine and carboxymethylcellulose. Int J Pharm. 2006;310:101–9.CrossRefGoogle Scholar
  41. 41.
    Akkaramongkolporn P, Yononemochi E, Terada K. Molecular state of chlorpheniramine in resinates. Chem Pharm Bull. 2000;48(2):231–4.PubMedCrossRefGoogle Scholar
  42. 42.
    Dahiya S, Pathak K. Influence of amorphous cyclodextrin derivatives on aceclofenae release from directly compressible tablets. Pharmazie. 2007;62:278–83.PubMedGoogle Scholar

Copyright information

© American Association of Pharmaceutical Scientists 2013

Authors and Affiliations

  • Wipada Samprasit
    • 1
  • Prasert Akkaramongkolporn
    • 1
  • Tanasait Ngawhirunpat
    • 1
  • Theerasak Rojanarata
    • 1
  • Praneet Opanasopit
    • 1
  1. 1.Pharmaceutical Development of Green Innovations Group (PDGIG), Faculty of PharmacySilpakorn UniversityNakhon PathomThailand

Personalised recommendations